{
  "company": {
    "name": "Reveal Pharmaceuticals",
    "website": "https://revealpharma.com/",
    "record": "https://startuphistory.org/c/revealpharma.com"
  },
  "status": null,
  "history_since": "2017-11-07T04:51:28.000Z",
  "baseline": {
    "snapshot_id": "7dbbc4daecbacd119036054de8572b833d3f750f5829ecd460668d6d17e559bd",
    "observed_at": "2017-11-07T04:51:28.000Z",
    "headline": "The Safe Gadolinium Free MRI Contrast Agent",
    "description": null,
    "evidence": "https://web.archive.org/web/20171107045128/http://www.revealpharma.com:80/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T20:29:57.552Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2018-08-04T14:45:27.000Z",
      "variants": [
        {
          "headline": "The Safe Gadolinium Free MRI Contrast Agent",
          "subhead": null,
          "observed_at": "2017-11-07T04:51:28.000Z",
          "evidence": "https://web.archive.org/web/20171107045128/http://www.revealpharma.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Gadolinium Free MRI Contrast Agent",
          "subhead": null,
          "observed_at": "2018-08-04T14:45:27.000Z",
          "evidence": "https://web.archive.org/web/20180804144527/http://revealpharma.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "The Gadolinium Free MRI Contrast Agent",
      "subhead": null,
      "from": "2017-11-07T04:51:28.000Z",
      "to": "2018-08-04T14:45:27.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20180804144527/http://revealpharma.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2017-11-07T04:51:28.000Z",
          "to": "2018-08-04T14:45:27.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-01-06T16:15:25.000Z",
      "variants": [
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2019-04-02T03:44:46.000Z",
          "evidence": "https://web.archive.org/web/20190402034446/http://www.revealpharma.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2020-01-17T05:56:36.000Z",
          "evidence": "https://web.archive.org/web/20200117055636/http://www.revealpharma.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2020-11-01T05:17:45.000Z",
          "evidence": "https://web.archive.org/web/20201101051745/http://www.revealpharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2021-12-17T06:22:53.000Z",
          "evidence": "https://web.archive.org/web/20211217062253/http://www.revealpharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2022-01-19T02:30:48.000Z",
          "evidence": "https://web.archive.org/web/20220119023048/http://www.revealpharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2024-07-11T14:48:03.000Z",
          "evidence": "https://web.archive.org/web/20240711144803/http://www.revealpharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2025-09-02T11:36:40.000Z",
          "evidence": "https://web.archive.org/web/20250902113640/http://www.revealpharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reveal Pharmaceuticals | Home",
          "subhead": null,
          "observed_at": "2026-01-06T16:15:25.000Z",
          "evidence": "https://web.archive.org/web/20260106161525/http://revealpharma.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Reveal Pharmaceuticals | Home",
      "subhead": null,
      "from": "2019-04-02T03:44:46.000Z",
      "to": "2026-01-06T16:15:25.000Z",
      "captures": 8,
      "evidence": "https://web.archive.org/web/20260106161525/http://revealpharma.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2019-04-02T03:44:46.000Z",
          "to": "2026-01-06T16:15:25.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T20:29:57.552Z",
      "variants": [
        {
          "headline": "Gadolinium-free contrast-enhanced MRI.",
          "subhead": "Reveal Pharmaceuticals is developing RVP-001, a gadolinium-free, manganese-based general purpose MRI contrast agent in Phase 2 clinical studies with FDA Fast Track designation.",
          "observed_at": "2026-11-06T20:29:57.552Z",
          "evidence": "https://www.revealpharma.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Gadolinium-free contrast-enhanced MRI.",
      "subhead": "Reveal Pharmaceuticals is developing RVP-001, a gadolinium-free, manganese-based general purpose MRI contrast agent in Phase 2 clinical studies with FDA Fast Track designation.",
      "from": "2026-11-06T20:29:57.552Z",
      "to": "2026-11-06T20:29:57.552Z",
      "captures": 1,
      "evidence": "https://www.revealpharma.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T20:29:57.552Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-88a733e825da224e4428d679a404398f0a81bd9b895c2e97a33d5f488cd4b969:4706bf2284fb6aba7b30fb0291b1179eb1346e6b8d0f9b7574e4672652f1e61d:compliance:784f18463d850bcc",
      "before_evidence": "https://web.archive.org/web/20180804144527/http://revealpharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "compliance",
      "label": "Compliance",
      "summary": "Now states FDA-APPROVED compliance on its homepage.",
      "between": {
        "from": "2018-08-04T14:45:27.000Z",
        "to": "2019-04-02T03:44:46.000Z"
      },
      "evidence": "https://web.archive.org/web/20190402034446/http://www.revealpharma.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-compliance"
    },
    {
      "n": 2,
      "id": "page-4ff369b1298e7cb7ad03e9dff3a478597e603f474e9f151ffc191d2e57aef0df:ad3f4b2923b4d67bc9dba1770ee3e5896ff5c5a932c48594a3b909cd1f6f2b1a:investors:c6ebe914e7ad2cc7",
      "before_evidence": "https://web.archive.org/web/20220119023048/http://www.revealpharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: National Cancer Institute (NCI), MassChallenge Winner, Mass Next Gen, MassVentures START and Endless Frontier Labs.",
      "between": {
        "from": "2022-01-19T02:30:48.000Z",
        "to": "2024-07-11T14:48:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20240711144803/http://www.revealpharma.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Reveal Pharmaceuticals” company record, https://startuphistory.org/c/revealpharma.com"
}